-
US Retail Sales and Fed Minutes Set Up a Critical Test for Consumers
-
Kansas City Fed Chief Says Inflation Is Still Running Too Hot
-
Oil Heads for Second Weekly Loss as Supply Surplus Emerges
-
Asian Markets Slide as AI Concerns Hit Chip Stocks
-
Brazil Faces Debt and Inflation Test as Lula Prepares Fourth Term
-
Tom Brady’s Viral Reaction to Deebo Samuel’s Trick-Play Touchdown
-
Canada Signals Openness to Chinese Automakers if US Trade Talks Fail
-
Canada Expands Asian Trade Push as US Negotiations Resume
-
US Mortgage Rate Falls for Fourth Week but Remains Above 7%
-
US Jobless Claims Rise to 200,000 but Layoffs Remain Historically Low
-
13 Native American-Owned Restaurants in Arizona to Experience Indigenous Culinary Traditions
-
Italy Raises 2026 Growth View but Warns Energy Will Keep Inflation High
-
Best Digital Photo Frames 2026: Aura, Skylight, and Amazon Compared
-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
-
India's Retail Inflation Reaches 6.09% as Food Prices Accelerate
-
India's Wholesale Inflation Jumps to 12.29% as Fuel Costs Surge
-
China's October Activity Data Reveal a Weak Start to the Fourth Quarter
-
Japan's Economy Edges Into Contraction as Costly Oil Weighs on Demand
-
South Korea Launches Probe into NewJeans Contract Controversy
-
Colin Farrell and Emma Fogarty on Friendship, Disability, and 'The Slightest Touch'
-
Helen Rees Reflects on Four Decades of South Africa's HIV Journey
-
Knicks Coach Mike Brown Unfazed by Josh Hart's Offensive Struggles
-
Foreign Investors Return to Indian Equities with ₹84,290 Crore Inflow
-
River Medway Reveals Financial Struggles Before 'Drag Race' Windfall
-
Interactive Map Reveals 1,000 Unsolved Murders Across UK
Sacklers, Purdue to pay $7.4 bn over opioid crisis
Several US states have reached a $7.4 billion settlement with the Sackler family and their pharmaceutical company Purdue over the opioid crisis that has ravaged the lives of millions of Americans, officials said Thursday.
The opioid crisis, which has caused more than 500,000 deaths over 20 years in the United States, has triggered a flurry of lawsuits against drugmakers, distributors and pharmacies from victims and the authorities.
Thursday's settlement, which will see funds routed to communities and individuals affected by opioids, is the largest of several targeting the makers and sellers of the highly addictive drugs.
The $7.4 billion settlement was agreed "in principle with members of the Sackler family and their company Purdue Pharma for their instrumental role in creating the opioid crisis," New York Attorney General Letitia James's office said in a statement.
"The settlement ends the Sacklers's control of Purdue and ability to sell opioids in the United States and will deliver funding directly to communities across the country over the next 15 years to support opioid addiction treatment, prevention, and recovery programs.
"The $7.4 billion settlement in principle (is) the nation's largest."
Purdue and other opioid makers and distributors were accused of encouraging free-wheeling prescription of their products through aggressive marketing tactics while hiding how addictive the drugs are.
- Litigation avalanche -
Facing an avalanche of litigation, in 2021 Purdue pled guilty to three criminal charges over its marketing of OxyContin.
The Sacklers have consistently denied wrongdoing over the opioid crisis.
The settlement featured some 15 states including New York, Florida and Pennsylvania.
"The Sackler family relentlessly pursued profit at the expense of vulnerable patients, and played a critical role in starting and fueling the opioid epidemic," James said in a statement.
"While no amount of money will ever fully repair the damage they caused, this massive influx of funds will bring resources to communities in need so that we can heal."
The settlement includes the eight heirs of the original Purdue founders Raymond and Mortimer Sackler who served on the company board -- Richard, Kathe, Mortimer Jr, Ilene, David, and Theresa Sackler.
For many people, opioid addiction begins with prescribed pain pills, before they increase their consumption and eventually turn to illicit drugs such as heroin and fentanyl, an extremely powerful synthetic opioid.
Opioid victims and their families addressed the Sackler family, owners of Purdue Pharma, the maker of OxyContin, directly in a US courtroom in March 2022 as part of the company's bankruptcy case.
"We buried Matthew and Kyle because of your family's vicious acts of disregard for human life," Liz Fitzgerald said of the deaths of two of her sons, who died at ages 32 and 25 after years of dealing with opioid addictions.
"Two boys are gone because of your 'safe' medication," Fitzgerald said.
P.Staeheli--VB